
Genentech scientist Bruce Roth says Lipitor nearly didn't make it to human testing.(AP)
The best-selling anti-cholesterol drug, Lipitor, had so much competition in early experimentation that it almost didn't make it to patient tests.
More
PLUS: Profit May Drive Hospice Care BLOG: Before you take that pill |
![]() ![]() Alcohol and drug abuse rates are soaring among seniors.
![]() An FDA panel's tentative approval of an Alzheimer's
test opens ethical questions.
![]() New guidelines advise doctors to do a better job preparing cancer patients for death.
|
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|
|
Ads by Google
News Updated Hourly from NBC11
NBC11's Web News On the Hour www.NBC11.com San Francisco-Oakland-San Jose CA |
|
Featured Sponsors Travel: Explore, enjoy and protect the planet. Finance: Find Value Stocks in all markets! Living: Verizon Broadband Calling Gardening: - 15% off orders of $25 or more! Home Office: 80GB iPod video $332.48 Cycling Supplies: Garmin Edge 305 GPS - Now $369.99 Health: Erase wrinkles with Hydroderm! |